Market Place
Sourcing Support
BostonGene Showcases AI Oncology Platform At JSMO 2026
25 Mar 2026 //
BUSINESSWIRE
BostonGene Advances AI Oncology Modeling At USCAP Meet
23 Mar 2026 //
BUSINESSWIRE
BostonGene Wins `Innovator Of The Year` At Boston Life Sciences
17 Mar 2026 //
PHARMIWEB
BostonGene, Unilever Partner For AI-Driven Consumer Innovation
03 Mar 2026 //
BUSINESSWIRE
BostonGene CEO Feinberg Keynotes Mobile World Congress Barcelona
24 Feb 2026 //
PHARMIWEB
BostonGene Wins Platinum for AI Research at 2025 Pinnacle Awards
17 Sep 2025 //
BUSINESSWIRE
BostonGene Wins 2025 AI Breakthrough Award for Drug Solution
07 Aug 2025 //
BUSINESSWIRE
BostonGene AI Platform Reveals Targets in Lobular Carcinoma, Wins
09 Jun 2025 //
BUSINESSWIRE
BostonGene to Showcase AI Platform at 2025 ASCO Annual Meeting
27 May 2025 //
BUSINESSWIRE
BostonGene Has 7 Abstracts At 2024 ASCO Annual Meeting
29 May 2024 //
BUSINESSWIRE
BostonGene Announces Cancer Immune Profiling Platform Publication In Cancer Cell
14 May 2024 //
BUSINESSWIRE
BostonGene Recognized as Designated Labs for the ComboMATCH Medicine Trial
26 Mar 2024 //
BUSINESSWIRE
BostonGene Announces Participation at the US and Canadian Annual Meeting
21 Mar 2024 //
BUSINESSWIRE
BostonGene Bolsters Leadership Team to Accelerate Innovation and Growth
22 Feb 2024 //
BUSINESSWIRE
BostonGene Announces Publication in Blood
20 Dec 2023 //
BUSINESSWIRE
BostonGene Named to the 2023 CB Insights` Digital Health 50 List
08 Dec 2023 //
BUSINESSWIRE
BostonGene Announces Ten Presentations at Society of Hematology Annual Meeting
07 Dec 2023 //
BUSINESSWIRE
BostonGene Wins Fierce Life Sciences Innovation Award
29 Nov 2023 //
BUSINESSWIRE
BostonGene to Showcase AI-Driven Molecular Profiling Solutions
13 Nov 2023 //
BUSINESSWIRE
BostonGene to Present Research with Leading Cancer Centers at Society
01 Nov 2023 //
BUSINESSWIRE
BostonGene Announces Poster Presentation at the 2023 CTOS
31 Oct 2023 //
BUSINESSWIRE
BostonGene and Exigent Research Announce Clinical Trial Agreement
24 Oct 2023 //
BUSINESSWIRE
BostonGene Announces Three Abstract Acceptances at ESMO Congress 2023
17 Oct 2023 //
BUSINESSWIRE
BostonGene Announces Agreement With Johns Hopkins University School of Medicine
03 Oct 2023 //
BUSINESSWIRE
BostonGene to Showcase Integrated Approach to Precision Medicine
20 Sep 2023 //
BUSINESSWIRE
BostonGene to Present Approach for Stratification and Selection of IO Trials
03 Aug 2023 //
BUSINESSWIRE
BostonGene and Sylvester Comprehensive Cancer Center Announce Collaboration
23 May 2023 //
BUSINESSWIRE
BostonGene Showcases Approach to Precision Medicine at Immuno-Oncology 360°
07 Feb 2023 //
BUSINESSWIRE
BostonGene Announces Publication in Cell Reports
04 Oct 2022 //
BUSINESSWIRE
BostonGene Announces Alliance with Massachusetts General Hospital Cancer Center
07 Sep 2022 //
BUSINESSWIRE
BostonGene Announces $150M Series B Funding
06 Apr 2022 //
BUSINESSWIRE
BostonGene Earns Recognition From Cancer Cell for State-of-the-Art Technology
22 Feb 2022 //
BUSINESSWIRE
BostonGene Expands Testing Capabilities to Predict Patient Response
08 Feb 2022 //
BUSINESSWIRE
BostonGene, WellDyne Partner for Immunotherapy Response, Reduce Cost of Care
11 Jan 2022 //
BUSINESSWIRE
BostonGene & MGH to Collaborate on Follicular Lymphoma
12 Oct 2021 //
BUSINESSWIRE
BostonGene and the Medical College of Wisconsin Announce Research Collaboration
27 Apr 2021 //
BUSINESSWIRE
BostonGene and Thomas Jefferson University Announce Research Collaboration
10 Nov 2020 //
BIOSPACE
Transgene, NEC & BostonGene Announce Collaboration for 2 Ongoing Clinical Trials
06 Oct 2020 //
PRESSRELEASE
